1[1]Mcheod BC, Sniecinski I, Ciavarella D. et al. Frequency of immediate adverse effects associated with therapeatic apheresis. Transfusion, 1999,39(3):282.
4[4]Strauss R,McLeod BC.Adverse reactions to therapeutic apheresis. In: Popovsky M , ed. Transfusion reactions. Bethesda, MD: AABB Press,1996.281-300.
5[5]Toby L. Simon, Bruce C. McLeod. Physiology of Apheresis. In: McLeod BC, Price TH, Drew MJ,eds. Apheresis: Principles and Practice Bethesda, MD: AABB Press,1997.67-79.
二级参考文献4
1[1]Moake JL.Studies on the pathophysiology of fhromboticthrom bocytopenic purpura.Semin Hematol,1997,34:83
2[2]Pavord S,kelron JG,Warner MN,et al.Proteolytic degradation of high molecular weight kininogen in acute throm boticthrombocytopenic purpura.Br J Haematol,1997,97:762
3Mcheod BC,Sniecinski I,Ciavarella D,et al.Frequency of immediate adverse effects associated with therapeutic apheresis.Transfusion,1999,39(3):282